London, UK | May 4, 2016– UK and European Symposium on Addictive Disorder (UKESAD) hosted a plethora of distinguished leaders in the behavioral healthcare field this week in London, England for its annual three-day conference. The largest European event of its kind, UKESAD draws more than 500 people each year.
Dr. Kathleen Bigsby, Foundation Recovery Network’s Group CEO, addressed the crowd of professionals on May 3 with a presentation titled “Passion as a Platform, Developing Your Organizational Culture Around What Matters Most.” During her talk, Dr. Bigsby focused on how FRN uses a “system of care” approach to positively impact measured outcomes and clinical services. This common system of care developed by FRN is used across all of the company’s residential treatment centers, outpatient centers, and support departments.
“UKESAD has been an incredible conference joining together with our international colleagues,” Dr. Bigsby said. “I have been honored and proud to represent Foundations Recovery Network there.”
About Kathleen Bigsby, PhD – FRN Group CEO (LCSW)
About Foundations Recovery Network
Foundations Recovery Network (FRN) is the premier provider of integrated treatment for co-occurring addiction and mental health concerns, offering residential and outpatient services nationwide. FRN is committed to providing evidence-based treatment for individuals with co-occurring disorders through clinical services, education and research. FRN offers treatment programs in Nashville and Memphis, Tennessee; Palm Springs, San Francisco, San Diego, Santa Monica, Los Angeles and Malibu, California; Atlanta and Sautee, Georgia; Chicago, Illinois; and Detroit and Augusta, Michigan. Each facility focuses on patient-centered care and an individualized approach, upholding a high standard of innovative treatment and compassionate attention to each patient’s needs.
For more information on Foundations Recovery Network visit: FoundationsRecoveryNetwork.com
For general press information and media inquiries contact:
Direct line: 615-221-0390
For all other treatment related questions, please call 866-491-6549.